Range Low Price High Price Comment
30 days $0.255 $0.255 Tuesday, 17th Sep 2019 INSY stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.191 $0.344
52 weeks $0.142 $10.44

Historical Insys Therapeutics prices

Date Open High Low Close Volume
Sep 17, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 16, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 13, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 12, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 11, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 10, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 09, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 06, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 05, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 04, 2019 $0.255 $0.255 $0.255 $0.255 0
Sep 03, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 30, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 29, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 28, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 27, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 26, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 23, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 22, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 21, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 20, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 19, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 16, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 15, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 14, 2019 $0.255 $0.255 $0.255 $0.255 0
Aug 13, 2019 $0.255 $0.255 $0.255 $0.255 0
Click to get the best stock tips daily for free!

About Insys Therapeutics

Insys Therapeutics Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ... INSY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT